WOAI-TV: Antiretroviral drug shows potential for Alzheimer’s disease treatment in early clinical trials
August 9, 2024
This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment. Watch Now
Clinical Trials Arena: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
For Worth Star-Telegram: UT Health San Antonio study — HIV drug may be effective against Alzheimer’s disease
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
MSN.com: UT Health San Antonio study: HIV drug may be effective against Alzheimer’s disease
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
Yahoo! Finance: UT Health San Antonio-led study shows lamivudine’s potential in Alzheimer’s
August 9, 2024
A. Campbell Sullivan, PsyD, ABPP-CN, clinical associate professor, Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases, was quoted in this article. Read More
AHRQ: Identifying and Disseminating Best Practices To Treat Long COVID
August 9, 2024
Monica Verduzco-Gutierrez, MD, professor and chair of the Department of Physical Medicine and Rehabilitation, and director of its long COVID clinics, was featured in this story. Read More
Mirage News — UT Health SA: Drug Shows Promise for Breast Cancer Brain Tumors
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of neuro-oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematolog …
Science Magazine: Drug shows promise for treating brain tumors resulting from breast cancer, UT Health San Antonio trial reports
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematolog …
Medical Xpress: Drug shows promise for treating brain tumors resulting from breast cancer, trial reports
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematolog …
News-Medical: Drug shows new promise in treating breast cancer with brain metastases or recurrent glioblastoma
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematolog …